S100A10 and prostate carcinoma: Compared to normal tissues, S100A10 was overexpressed in bladder cancer, brain cancer, breast cancer, GC, head and neck cancer, kidney cancer, leukemia, liver cancer, lymphoma, myeloma, pancreatic cancer, and prostate cancer (Figure 1A).